[MEDIA] The National Advisory General Medical Sciences advises that it's council meeting scheduled for TODAY has been postponed. It's the second...
Not optimistic https://en.wikipedia.org/wiki/Trimetazidine
Hypertension not MECFS, but pretty interesting. Highlights • The serum α-lipomycin level and fecal mRNA level of LipReg4 are elevated in HSD...
The search function is your friend. ETA there has already been a lot of discussion of this individual.
This conference looks good except for P*trino. Is anyone here going to this? It looks like the 2nd day will be posted later to youtube, but not...
Merged thread Simmaron’s Rapamycin ME/CFS Trial Moves Forward: The Goal – FDA Approval Cort Johnson...
[MEDIA] The largest medical #AI randomized controlled trial yet performed, enrolling >100,000 women undergoing mammography screening, was...
I think the resistance is only relevant to multiple myeloma.
AI better than physicians. (With Eric Topol)...
Abstract Anti-CD38 monoclonal antibodies like Daratumumab (Dara) are effective in multiple myeloma (MM); however, drug resistance ultimately...
Cost is about US $15/pill
https://www.fiercepharma.com/pharma/vertex-scores-fda-nod-long-awaited-non-opioid-pain-reliever-journavx So approved for acute pain, not chronic...
From Ingrid Rekeland’s dissertation on the cyclophosphamide trial and from recent data from the Daratumumab trial it appears that patients with...
A week of pain and confusion for medical researchers https://wapo.st/4aEKtOU
Does this have finding have implications for the plasma cells that derive from these B cells? Any chance they will be abnormal?
Yes, that was sarcastic.
He is a cutting-edge Long Covid researcher!!
https://bsky.app/profile/putrinolab.bsky.social/post/3lfvd7ciapc25 Since my episode with the wonderful @longcovidanswer has been released...
It’s muddied the waters. I believe I made a thread about this on here. For example, AP has brought in a bunch of money for LC research but it’s my...
FWIW, this recent preprint also noted significant differences between severe and mild/moderate patients albeit with different markers....
Separate names with a comma.
